Acclaimed Author Reveals How Her New Book Could Save Nurse Entrepreneurs Thousands Of Dollars.

Daily Actionable Tasks To Start Your Nursing Business

The NursePreneur Mentor

Dr. Catie Harris

Dr. Catie Harris, NursePreneur Mentor, acclaimed author & leading expert in teaching nurses to start businesses, reveals her proven system in her latest book.

PHILADELPHIA, PA, USA, September 27, 2018 /EINPresswire.com/ — Dr. Catie Harris, CEO and President of NursePreneurs, the premier agency for nurse entrepreneurs has written the forthcoming book titled, 100 Days Of Action: Build Your Online Nursing Business.

In this highly anticipated release, Dr. Harris has painstakingly taken the guessing of what to do today or what to do next out of the equation for aspiring NursePreneurs who want the freedom of working from anywhere on their own schedule.

Online nursing businesses are skyrocketing and Dr. Harris is paving the way for more nurses to get started.
Any nurse who is even thinking about an online business or have a presence online needs to order this book.

100 Days Of Action teaches nurses where to start with their business, what to do first and how to follow a proven path to success.

100 Days of Action is broken down into 10 main chapters which helps readers to organize their thought process around the segments of their business that need to be addressed first. Each chapter builds on the prior one.

If you follow Dr. Harris’ system and take one action a day, you are sure to save yourself time, headaches and potentially thousands of dollars paying other people to tell you what to do next.

100 Days Of Action is scheduled for release in October 2018.

https://catieharris.com/100-days/

Catie Harris
NursePreneurs
email us here
6093323852
Visit us on social media:

Facebook
LinkedIn


Source: EIN Presswire

Bringing Mental Health Rights to Parents and Veterans at the Congressional Black Caucus Annual Legislative Conference

The public were informed by Citizens Commission on Human Rights Volunteers at the Congressional Black Caucus Foundation’s 48th Annual Legislative Conference

A veteran is welcomed to the Citizens Commission on Human Rights display and learns about issues affecting veterans’ mental health at the Congressional Black Caucus Foundation’s 48th Annual Legislative Conference

Participants are briefed on their rights in the mental health system by Citizens Commission on Human Rights Volunteers at the Congressional Black Caucus Foundation’s 48th Annual Legislative Conference

CCHR exposes targeting of African Americans with false psychiatric diagnosis and dangerous medications as a human rights violation.

The psychiatric-pharmaceutical industry is not a public service. Its interests are new markets to tap and getting more customers for longer… One of those markets is the African American community.”

— Dr. Linda Lagemann

WASHINGTON DC, DISTRICT OF COLUMBIA, UNITED STATES, September 27, 2018 /EINPresswire.com/ — Citizens Commission on Human Rights exposes the targeting of African Americans with false psychiatric diagnosis and dangerous medications as a human rights violation. Facts about mental health rights provided as a shield against such abuse.

Citizens Commission on Human Rights (CCHR) brought its “Restoring Human Rights & Diginity to the Field of Mental Health” campaign to the 2018 Congressional Black Caucus Foundation Annual Legislative Conference to educate African-American parents and veterans about their rights and warn them of the dangers of psychiatric drugs.

This included a 2-hour “Ask the Expert” session led by Dr. Linda Lagemann, national media commentator on the mental health system. Parents and grandparents stopped by to receive information and learn their rights when a psychiatrist, doctor or school professional says their child has a “mental disorder” and needs to be on “medication.”

“Psychiatric diagnoses are entirely subjective – different psychiatrists seeing the same person often come up with different diagnoses. This subjectivity is vulnerable to prejudice and may explain why studies find African American males are disproportionately given a psychiatric diagnosis,” said Dr. Linda Lagemann. She further explained, “The psychiatric-pharmaceutical industry is not a public service. Its interests are new markets to tap and getting more customers for longer. One of those markets is younger and younger children. Another of those markets is the African American community, which historically did not drug their children at the same rate as white parents.”

CCHR cautions parents to know their rights and arm themselves with the documented facts. For instance, many do not know that Federal law prohibits school personnel from requiring parents to drug their child as a requisite for attending school (Title 20 of United States Code: Chapter 33, Subchapter II, ASSISTANCE FOR EDUCATION OF ALL CHILDREN WITH DISABILITIES § 1412, State Eligibility.)

CCHR also focused on the subject of veteran suicide offering free copies of The Hidden Enemy documentary DVD to the military, veterans, members veteran support groups, family or associates of active-duty personnel or veterans, present at the Congressional Black Caucus Conference.

In 2013, the U.S. Department of Defense announced a startling statistic: The number of military suicides in 2012 had far exceeded the total of those killed in battle. One month later, the U.S. Department of Veterans Affairs revealed that veteran suicide was running at 22 a day—about 8,000 each year.

A Chaplain from the U.S. Department of Veterans Affairs who is in charge of counseling military that return from war zone told a CCHR volunteer: “I know all about this. I witness it first-hand when I help soldiers reintegrate into society after being in a war zone. That is why I always wear a bracelet that has number 22 engraved on it.”

CCHR’s volunteers also provided attendees with a copy of the Mental Health Declaration of Human Rights and educational materials that help avoid unconsented psychiatric labeling and drugging.

The 48th Congressional Black Caucus Foundation Annual Legislative Conference was held at the Walter E. Washington Convention Center in Washington D.C. with the theme “The Dream Still Demands Courage, Resilience, Leadership and Legislation.” The five-day conference attracts annually nearly 10,000 people from across the world and is the leading policy conference on issues impacting African Americans and the global Black community. The conference featured nearly 100 public policy forums on health, education, economic empowerment, the environment, and more.

Citizens Commission on Human Rights is a nonprofit charitable mental health watchdog cofounded in 1969 by the Church of Scientology and professor of psychiatry Dr. Thomas Szasz. It is dedicated to eradicating psychiatric abuse and ensuring patient protection.
With headquarters in Los Angeles, California, CCHR International guides a global human rights advocacy network of some 180 chapters across 34 nations. CCHR Commissioners include physicians, psychiatrists, psychologists, lawyers, legislators, government officials, educators and civil rights representatives.
For more information about materials or participation in the Citizens Commission on Human Rights Washington DC, contact (202)-349-9267 or write to isabelle.vladoiu@cchrdc.org or go to the website at https://www.cchr.org/

Isabelle Vladoiu
Citizens Commission on Human Rights
(202)-349-9267
email us here


Source: EIN Presswire

IT Governance USA launches West Coast GDPR courses

IT Governance, the global cybersecurity experts.

NEW YORK, NEW YORK, UNITED STATES, September 27, 2018 /EINPresswire.com/ — IT Governance USA is pleased to announce the launch of its onsite GDPR (General Data Protection Regulation) courses on the West Coast to help organizations in the region achieve compliance with international standards and best-practice guidelines.
The following course will be running:

• Certified EU General Data Protection Regulation Foundation (GDPR) Training Course

Date: October 29, 2018, 9:00 am – 5:00 pm PST
Location: San Francisco (MicroTek)
Price: $619

Date: November 26, 2018, 9:00 am – 5:00 pm PST
Location: Los Angeles (MicroTek)
Price: $618
This one-day introductory training course will give attendees a comprehensive introduction to the GDPR and a practical understanding of the implications and legal requirements for U.S. organizations. Click here to register.

NOTES TO EDITORS
IT Governance USA is the single-source provider of books, tools, training, and consultancy for IT governance, risk management, and compliance. It is a leading authority on data security and IT governance for business and the public sector. IT Governance is ‘non-geek’, approaching IT issues from a non-technology background, and talking to management in its own language. Its customer base spans Europe, the Americas, the Middle East, and Asia. More information is available at www.itgovernanceusa.com.
###

Mitchell Slepian
IT Governance USA
email us here
+ 1 917-794-3109
Visit us on social media:

Facebook
Twitter
LinkedIn


Source: EIN Presswire

SMi’s release speaker interview for Anita Burrell, speaking at Biosimilars USA conference

Biosimilars USA 2018

SMi Reports: An exclusive interview with Anita Burrell, speaker at this year’s 5th annual Biosimilars USA conference, available to download on the event website

ISELIN, NEW JERSEY, UNITED STATES , September 27, 2018 /EINPresswire.com/ — SMi Group recently caught up with expert speaker Anita Burrell, Founder & CEO at Anita Burrell Consulting, in the run up to the conference on Biosimilars USA conference, taking place in Iselin, NJ, USA on November, 14 and 15.

Anita Burrell is a dynamic, passionate and infectiously enthusiastic consultant focused on improving patient outcomes through pharmaceutical innovation. She is also an adjunct assistant professor at Rutgers University and a regular speaker in the industry on health economics, market access and mHealth.

Anita has 23 years of leadership experience in the pharmaceutical industry in a wide variety of roles and geographies. As the Global Project Lead for Aubagio, the oral MS therapy from Genzyme, she was able to bring Aubagio to market over eight months ahead of schedule becoming the second oral therapy to market in the USA and EU. Aubagio is the fastest growing MS product in the US and the #1 product in the Genzyme/Sanofi portfolio with revenue of €1.6B in 2017.
Interview Snapshot:

What is your area of expertise within the Biosimilars field and why are you supporting the Biosimilars USA conference for 2018?
My background is in value demonstration, mainly for innovative pharmaceuticals, but I became interested in the biosimilar field when I was asked a very provocative question, “Do you think that biosimilars need to have Real World Evidence?”. Given that I have a lot of experience in collecting and using RWE for pharmaceuticals I wanted to explore the question in detail and this led to a series of articles that I wrote to explore the topic. I wanted to bring this subject to the conference for the attendees, firstly as an exploration of my findings and then to continue the discussion around this topic.

What do you see as the greatest hurdle/ challenge to overcome in the Biosimilars field within the US market?
Acceptance of biosimilars in the USA has been a major issue in delivering the promise of creating financial and budgetary headroom for drugs. Market access depends on acceptance at all levels of the healthcare system, patients, physicians as well as payers and the reasons for the slower uptake can be tracked to regulatory, judicial and stakeholder reluctance. For me the main challenge for biosimilars in the US market will be dealing with these issues so that we can realize the benefits of these products and enhance the efficiency of the healthcare system in those areas where biosimilars can play a role.

What do you think could be and should be done to address this?
The FDA is already making strides to encourage the biosimilar field but there are a number of policy and regulatory barriers to…………

This year’s Biosimilars USA conference will provide delegates with the opportunity to hear from a selection of in-depth keynote addresses and case studies presented by top manufacturing and leading distributors of market-approved biosimilars, as they offer a unique insight into the areas of manufacturing, commercialization, device design, uptake, switching, interchangeability, and regulations.

The latest conference brochure, as well as other exclusive content including the full speaker line-up and an interview with expert speaker Anita Burrell, are now available to download on the event website, where you can also register your place: www.biosimilars-usa.com/pr3

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Biosimilars USA
14th – 15th November 2018
Renaissance Woodbridge Hotel,
Iselin, New Jersey, USA
www.biosimilars-usa.com/pr3

Follow us @SMiPharm
#SMiBioSimUSA

—- END —-

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Simi Sapal
SMi Group
02078276000
email us here


Source: EIN Presswire

Sports Nutrition Market Expected to Reach 4300 million US$ by 2023 Says Report at MarketResearchNest.com

Market Research Nest Reports

Market Research Nest Reports

MarketResearchNest.com adds “Global Sports Nutrition Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023” new reports to its research

PUNE, INDIA, September 27, 2018 /EINPresswire.com/ — This report studies the Sports Nutrition market with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Sports Nutrition market analysis segmented by companies, region, type and applications in the report.

Sports nutrition products include sports drinks, supplements, and food that include protein powders, Isotonic drink powder, capsule/tablets (creatine/branched chain amino acids and others), supplement powder, ready-to-drink protein drinks, carbohydrate drinks, protein bars, carbohydrate/energy bars and other supplements.

Scope of the Report:
This report focuses on the Sports Nutrition in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
• The sports nutrition market is expected to witness significant growth within the forecast period on account of increasing demand from recently emerging lifestyle and recreational users. In addition, increasing health awareness coupled with increasing number of health clubs and fitness centers is also expected to boost this market within the forecast period.
• Rapid urbanization and increasing disposable income are also expected to boost growth in the sports nutrition market. The high number of cheap counterfeit products affects sales of reputed companies and therefore, availability of these products is expected to restrict the growth of sports nutrition market. Expansion of distribution channels is also expected to be an opportunity for growth in this market in coming years.
• The worldwide market for Sports Nutrition is expected to grow at a CAGR of roughly 7.7% over the next five years, will reach 4300 million US$ in 2023, from 2760 million US$ in 2017, according to a new GIR (Global Info Research) study.

Inquiry before buy this report @
https://www.marketresearchnest.com/report/enquirybuy/440718 .

Sports Nutrition market continues to evolve and expand in terms of the number of companies, products, and applications that illustratesthe growth perspectives.The report also covers the list of Product range and Applications with SWOT analysis, CAGR value, further adding the essential business analytics. Sports Nutrition market research analysis identifies the latest trends and primary factors responsible for market growth enabling the Organizations to flourish with much exposure to the markets.

Market Segment by Companies, this report covers:
Atlantic Multipower UK
CLIF Bar and Company
Glanbia
ProAction
Weider Global Nutrition

Market Segment by Regions, regional analysis covers:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Browse full table of contents and data tables@
https://www.marketresearchnest.com/Global-Sports-Nutrition-Market-2018-by-Manufacturers-Regions-Type-and-Application-Forecast-to-2023.html .

The Sports Nutrition market research report completely covers the vital statistics of the capacity, production, value, cost/profit, supply/demand import/export, further divided by company and country, and by application/type for best possible updated data representation in the figures, tables, pie chart, and graphs. These data representations provide predictive data regarding the future estimations for convincing market growth. The detailed and comprehensive knowledge about our publishers makes us out of the box in case of market analysis.

Market Segment by Type, covers:
Sports Protein Powder
Sports Protein Ready-To-Drink (RTD)
Non-Protein Products
Sports Protein Bars

Market Segment by Applications, can be divided into:
Large Retail and Mass Merchandisers
Small Retail
Drug and Specialty Stores
Fitness Institutions
Online Retail

Key questions answered in this report
• What will the market size be in 2023 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Order a Purchase Report Copy @
https://www.marketresearchnest.com/report/purchase/440718 .

Point’s covered in TOC:
• Sports Nutrition Market Overview
• Manufacturers Profiles
• Global Sports Nutrition Market Competition, by Players
• Global Sports Nutrition Market Size by Regions
• North America Sports Nutrition Revenue by Countries
• Europe Sports Nutrition Revenue by Countries
• Asia-Pacific Sports Nutrition Revenue by Countries
• South America Sports Nutrition Revenue by Countries
• Middle East and Africa Revenue Sports Nutrition by Countries
• Global Sports Nutrition Market Segment by Type
• Global Sports Nutrition Market Segment by Application
• Global Sports Nutrition Market Size Forecast (2018-2023)
• Research Findings and Conclusion
• Appendix

About Us:
MarketResearchNest.com Market Research Nest (MRN) is an offering of GRN Research Pvt. Ltd. It is a one-stop-shop for market research products and services. At MRN, we offer reports from almost all top regional and global publishers and research firms who specialize in their domains. We ensure that you receive the most reliable and up to date research data. We update our collection daily to help our clients have an access to a most up-to-date database of expert insights on global industries, organizations, products, and trends. Our database covers research studies including periodic updates on a range of industries, companies, products, SWOT profiles, recent marketing, and other trends.

Contact us: –
Mr. Jeet Jain
Sales Manager
sales@marketresearchnest.com
+1-240-284-8070, +44-20-3290-4151

Mr Jeet
Market Research Nest
1-240-284-8070
email us here


Source: EIN Presswire

Global Conjugate Vaccine Market Research and Forecast, 2018-2023

Conjugate Vaccine Market Research By OMR

Orion Market Research (OMR Global)

Global Conjugate Vaccine Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Increasing regulatory approvals of conjugate vaccines is driving the growth of conjugate vaccine market”

— OMR Analyst

INDORE, INDIA, September 27, 2018 /EINPresswire.com/ — According to the OMR analysis, the global conjugate vaccine market is growing at a significant CAGR during 2018-2023. The global conjugate vaccine market has witnessed a significant growth due to government initiatives towards development and awareness of conjugate vaccines and longer immunity and better safety of conjugate vaccines. The global conjugate vaccine market is segmented on the basis of product type, disease, patient type, pathogen and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, pipeline analysis, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights. and predictive analysis of the market.

Full report of global conjugate vaccine market is available at: https://www.omrglobal.com/industry-reports/conjugate-vaccine-market/

Rising prevalence of infectious diseases caused by microorganisms such as Neisseria meningitides is the major motivator for the market. Complex manufacturing process of conjugate vaccines is one of the major restraints that have been hindering the market growth. Additionally, low accessibility to these vaccines in remote areas affects the market growth in various countries. However, promising pipeline products in the upcoming years as well as rising awareness due to regular vaccination campaigns is expected to drive the future market growth. Furthermore, advancements in manufacturing process which would make the production simpler and cost effective will motivate the market in the upcoming years.

On the basis of the geography, conjugate vaccines market is segmented into North America, Asia Pacific, Europe and Rest of the World. North America has been predicted to dominate the global conjugate vaccines market to due to rise in demand for meningococcal vaccines, pneumococcal, and other conjugate vaccines. Additionally, high healthcare spending as well as availability of reimbursement policies in the region makes it a dominant region for the growth of the market. APAC will be the fastest growing region during the forecast period. APAC is expectedpredicted to show significant growth due to rising geriatric population and increasing incidence and prevalence rate of infectious diseases. Furthermore, rising awareness and government initiatives towards these vaccines distribution has been driving the market growth in this region.

The report covers:
Comprehensive research methodology of global conjugate vaccine market.
This report also includes detailed and extensive market overview with analyst insights & key market trends.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global conjugate vaccine market.
Insights about market determinants which are stimulating the global conjugate vaccine market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/pharmaceuticals/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:

LinkedIn

Global Conjugate Vaccine Market Research By OMR


Source: EIN Presswire

Global Bioabsorbable Stents Market Research and Forecast 2018-2023

Bioabsorbable Stents Market Research By OMR

Orion Market Research

Bioabsorbable Stents Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Rising incidence and prevalence of life style oriented diseases are driving the growth of bioabsorbable stent market”

— OMR Analyst

INDORE, INDIA, September 27, 2018 /EINPresswire.com/ — According to the OMR analysis, the global bioabsorbable stent market is expected to decline during forecast period 2018-2023. The global bioabsorbable stent market has witnessed its growth to slow down due to poor outcomes and poor intimal healing after the procedure of implantation. The global bioabsorbable stent market is segmented on the basis of polymer type, drugs, applications, end users and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights.

Full report of global bioabsorbable stent market is available at: https://www.omrglobal.com/industry-reports/bioabsorbable-stents-market/

“A slow adoption rate has been witnessed in the market for bioabsorbable stent due to the high risk of complications associated with its implantation. There was an increasing shift towards the bioabsorbable stent from the conventional metallic drug-eluting stents (DES). However, recent data from the clinical trial has changed the perception. As a result of which, the players in the market are about to end the sell of bioabsorbable stent. For instance: the clinical trial of the ABSORB stent by Abbott showed poor outcomes with no long-term benefits. In addition, the clinical trial showed a significant increase in the target lesion failure. As a result of which, Abbott has decided to pull of the sales of its bioabsorbable stent as of September 2017. In addition, another major player Boston Scientific has halted its investment for this technology. The end of the sale of bioabsorbable stents by such market players may result into the end of the market in the coming years.”

The market on the basis of geography is divided among four major regions which includes North America, APAC, Europe, and Rest of the world. North America has been dominating the bioabsorbable stent market due to highest healthcare spending, sophisticated healthcare system, and large pool of target population. The rise in the number of cardiovascular patient and increasing medical tourism in the APAC region, economic developments and government reforms, especially in countries such as China and India, are supporting market growth in this region.

The report covers:
Comprehensive research methodology of Global Bioabsorbable Stents Market.
This report also includes detailed and extensive market overview with Analyst insights & key market trends.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Bioabsorbable Stents Market.
Insights about market determinants which are stimulating the Global Bioabsorbable Stents Market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/healthcare/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:

LinkedIn

Global Bioabsorbable Stents Market Research By OMR


Source: EIN Presswire

Global EPO Biomarkers Market Research and Forecast 2018-2023

Global EPO Biomarkers Market Research By OMR

Orion Market Research

Global EPO Biomarkers Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Growing adoption of EPO biomarkers for the treatment of aids, neurological, and haematological diseases, is driving the market growth”

— OMR Analyst

INDORE, INDIA, September 27, 2018 /EINPresswire.com/ — According to the OMR analysis, the global EPO biomarkers Market is expected to grow impressively during 2018-2023. The global EPO biomarkers market is segmented on the basis of biomarker type, applications, and end users. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, sector analysis, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights, and predictive analysis of the market.

Full report of global EPO biomarkers market is available at: https://www.omrglobal.com/industry-reports/epo-biomarkers-market/

The global EPO biomarkers market has witnessed a steady growth due to increasing illness of chronic illnesses such as cancer and kidney disorder and a favorable reimbursement policy has increased the demand for EPO biomarkers. Moreover, growing adoption of EPO biomarkers for the treatment of AIDS, neurological, hematological, and end-stage renal diseases is fueling the growth of the global EPO biomarkers market. According to the statistics provided by the World Health Organization (WHO), around 50 million people are suffering from epilepsy, making it one of the most common neurological diseases across the globe. On the basis of biomarker type, the global EPO biomarkers market is segmented into six broad categories, namely, erythropoietin alfa, erythropoietin beta, erythropoietin zeta, erythropoietin theta, recombinant human erythropoietin, and darbepoetin alfa. The erythropoietin alfa EPO biomarker is estimated to hold the largest share in the global EPO biomarker market due to its increased adoption in the treatment of cancer and other end-stage renal diseases.

Global EPO biomarkers market by region is segmented into North America, Europe, Asia-Pacific, and rest of the world. Asia-Pacific is expected to exhibit the fastest growth in the near future due to increasing prevalence of hematological diseases in the region, especially in India, China, Pakistan, and Bangladesh. The presence of local EPO biomarker manufacturers along with the low cost of treatment therapy are some of the major factors that are significantly contributing in the market growth. North America holds a dominant position in the global EPO biomarkers market in 2017, owing to favorable reimbursement policies and improved healthcare infrastructure in the region. Furthermore, the rising acceptance for bio-similar is another factor that is significantly contributing in the market growth.

The report covers:
Comprehensive research methodology of global EPO biomarkers market
This report also includes detailed and extensive market overview with key analyst insights
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations
Analysis of regional regulations and other government policies impacting the global EPO biomarkers market
Insights about market determinants which are stimulating the global EPO biomarkers market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

For related reports please visit https://www.omrglobal.com/reports-category/biotechnology/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:

LinkedIn

Global EPO Biomarkers Market Research By Orion Market Research


Source: EIN Presswire

Global Cardiomyopathy Market Research and Forecast 2018-2023

Global Cardiomyopathy Market Research By OMR

Orion Market Research

Cardiomyopathy market, size, share, market intelligence, company profiles, market trends, strategy, research report, analysis, forecast 2018-2023

Rising adoption of minimally invasive technology is driving the growth of cardiomyopathy market”

— OMR Analyst

INDORE, INDIA, September 27, 2018 /EINPresswire.com/ — According to the OMR analysis, the global cardiomyopathy market is growing significantly during the forecast period (2018-2023). The global cardiomyopathy market has witnessed a significant growth due to rise in incidences of congestive heart failure, coronary heart disease, and heart attack. The global cardiomyopathy market is segmented on the basis of type, diagnosis test, treatment and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, company profiling, market segmentation, geographical analysis, analyst insights.

Full report of global cardiomyopathy market is available at: https://www.omrglobal.com/industry-reports/cardiomyopathy-market/

“The cause of the cardiomyopathy is unknown. Contributing factors for acquired cardiomyopathy include long-term high blood pressure, heart tissue damage from a heart attack, chronic rapid heart rate, heart valve problems, metabolic disorders, such as obesity, thyroid disease or diabetes and nutritional deficiencies of essential vitamins or minerals, such as thiamin (vitamin B-1).

The doctor diagnose cardiomyopathy based on patient’s medical and family histories. Often, a cardiologist or pediatric cardiologist diagnoses and treats cardiomyopathy. These doctors specialize in heart diseases. Diagnostic test includes chest x-ray, echocardiogram, electrocardiogram (ECG), treadmill stress test, cardiac catheterization, cardiac MRI, cardiac CT scan, blood tests and genetic testing or screening. After the diagnosis of cardiomyopathy, medical procedures are performed. The result of diagnostic test may be used to prepare for surgery, if surgery is planned. These procedures may include coronary angiography, cardiac catheterization, or myocardial biopsy.
The market on the basis of geography is divided among four major regions – North America, APAC, Europe, and Rest of the world. North America is the leading market. The market is expected to grow considerably during the forecast period. North American market is driven due to growing geriatric population and increasing heart diseases. Asia Pacific market is expected to have the highest CAGR amongst all regions for the forecast period of 2018-2023. The rapidly developing healthcare infrastructure and growing demand for minimally invasive surgery in the region are supporting growth of this region.

The report covers:
Comprehensive research methodology of global cardiomyopathy market
In-depth analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the global cardiomyopathy market
Insights about market determinants which are stimulating the global cardiomyopathy market
Detailed and extensive market segments with regional distribution of forecasted revenues
Extensive profiles and recent developments of market players

For related reports please visit: https://www.omrglobal.com/reports-category/medical-devices/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:

LinkedIn

Global Cardiomyopathy Market Research By Orion Market Research


Source: EIN Presswire

Global Spirometer Market Research and Forecast 2018-2023

Global Spirometer Market Research By OMR

OMR

Global Spirometer Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Increasing prevalence of copd and rising geriatric population enables to accelerate the global spirometer market”

— OMR Analyst

INDORE, INDIA, September 27, 2018 /EINPresswire.com/ — According to OMR analysis the global spirometer market is expected to grow significantly during the forecast period (2018-2023). The global spirometer market has been segmented on the basis of product type, technology, application, disposable component and end-users. The report provides detailed & insightful chapters which includes market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, and geographical analysis.

Full report of global spirometer Market is available at: https://www.omrglobal.com/industry-reports/spirometer-market/

Increasing prevalence of COPD is the major factor driving the global spirometer market. According to WHO, there were 251 million cases of COPD registered globally in 2016. It was estimated that 3.17 million deaths globally were occurred due to COPD in 2015. It was represented 5% of all deaths globally in 2015. Over 90% of COPD deaths occur in low and middle-income countries. COPD is expected to rise in future coupled with increasing aging population. The older people are mainly prone to the adverse health effects associated with respiratory disorders. The decline in respiratory function has been observed with the rising age and therefore, managing airways are required which leads the demand for spirometers. According to United Nations, in 2017, there were an estimated 962 million people are aged 60 or above. It represents 13% of the global population. Additionally, the population aged 60 years or over is rising with the rate of nearly 3%. Europe has the highest percentage of population aged 60 years or above which is nearly 25%. However, the ageing population is growing rapidly in other parts and hence by 2050, the number of ageing population globally is anticipated to be 1.4 billion in 2030 and 2.1 billion in 2050. This increasing prevalence of COPD coupled with ageing population is boosting the demand for spirometer as it is the most reliable way to test the lungs for asthma and COPD. This enables to understand the patient’s condition and further enables for the treatment. This, in turn, is expected to fuel the global spirometer market.

Furthermore, in June 2018, Henry Schein Medical introduced its new EasyOne Air spirometer. It is a new all-in-one solution for the testing of lung function that enables to potentially diagnose and improves recognition of COPD. It features a premium touch screen interface that enables medical professionals to easily enter data and navigate, as well as monitor real-time curves. Unlike most spirometers that need every day calibration to generate precise results, EasyOne Air utilizes TrueFlow, a calibration-free and resistance technology in order to ensure accuracy and remove potential errors. It also comprises wireless connectivity to a personal computer through Bluetooth that allows patients to monitor interactive software displays, including real-time graphs and animated incentive screens. As a result, it is expected to encourage adults and children for gaining maximum result through participating in a spirometry test. The additional features of this device comprise electronic medical record and data exchange connectivity. In April 2018, NuvoAir has introduced Air Next, a revolutionary home-use spirometer that enables users to measure the lung performance. It has a smooth design that suits into the hand palm. In addition, it can measure all the parameters that are recorded by medical professionals. Such technological innovations enable to boost the efficiency of the device and encourage the users to adopt for accurate diagnosis of the lung conditions.

The report covers:
Comprehensive research methodology of global spirometer market.
This report also includes detailed and extensive market overview with key analyst insights.
Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Spirometer Market.
Insights about market determinants which are stimulating the global spirometer market.
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.

For related reports please visit: https://www.omrglobal.com/reports-category/medical-devices/

About Orion Market Research
Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
+919179828694
email us here
Visit us on social media:

LinkedIn

Spirometer Market Research By OMR


Source: EIN Presswire